Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional). Standard AIDS dates apply.

PAR-20-123

NIH

Pre-Solicitation Notice: Resources to Advance Pediatrics and HIV Prevention Science (RAPPS), RFP: 75N93021R00020

NOT-AI-22-035

NIH

HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)

PAR-22-248

NIH

Letter of Intent Deadline: Jan 07 2023

Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Optional)

RFA-MH-25-186

NIH

Letter of Intent Deadline: Jul 13 2024

Advancing HIV service delivery through pharmacies and pharmacists (R01 Clinical Trial Optional)

RFA-MH-25-185

NIH

Letter of Intent Deadline: Jul 13 2024

Engineering Durable HIV Vaccine Responses (ENDURE) (R01 Clinical Trial Not Allowed)

RFA-AI-24-025

NIH

Letter of Intent Deadline: Sep 09 2024

Elucidating Mechanisms Associated with HIV Related Co-Morbidities in Populations Experiencing Health

RFA-MD-24-005

NIH

Letter of Intent Deadline: Dec 07 2024

NIAID Research Opportunities for New and “At-Risk” Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)

PAR-22-241

NIH

Notice of Special Interest (NOSI): Research on the Health of Bisexual and Bisexual+ People

NOT-OD-22-166

NIH

Application Deadline: May 08 2025 at 3:23pm